Contact Us
  Search
The Business Research Company Logo

Malaria Treatment Market Report 2026

Buy Now
Global Malaria Treatment Market Report 2026
Published :January 2026
Pages :150
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Malaria Treatment Market Report 2026

Global Outlook – By Treatment (Prescription Medications, Vaccines, Diagnostic Tests, Other Treatments), By Route Of Administration (Oral, Parenteral, Intravenous), By Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels), By End User (Hospitals, Specialty Clinics, Homecare, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035

Malaria Treatment Market Overview

• Malaria Treatment market size has reached to $1.61 billion in 2025 • Expected to grow to $2.18 billion in 2030 at a compound annual growth rate (CAGR) of 6.5% • Growth Driver: A Rising Tide Of Cases Propels Growth In The Malaria Treatment Market • Market Trend: Vaccine Rollouts Lead the Fight Against Malaria: Gavi Launches R21 Vaccine to Protect Children Under Five • Middle East and Africa was the largest region in 2025 and Asia-Pacific is the fastest growing region.
Research Expert

Book your 30 minutes free consultation with our research experts

What Is Covered Under Malaria Treatment Market?

Malaria treatment refers to the medical interventions and procedures used to diagnose, manage, and cure malaria, which is a potentially life-threatening mosquito-borne disease caused by the Plasmodium parasite. The main malaria treatment includes prescription medications, vaccines, diagnostic tests, and others. Prescription medications refer to drugs that can only be obtained with a valid prescription from a healthcare professional, which are used in malaria treatment to provide targeted and regulated therapy for the infection. They are administered through oral, parenteral, and intravenous routes and are distributed by direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and other channels for hospitals, specialty clinics, home care, and other end users.
Malaria Treatment Market Global Report 2026 Market Report bar graph

What Is The Malaria Treatment Market Size and Share 2026?

The malaria treatment market size has grown strongly in recent years. It will grow from $1.61 billion in 2025 to $1.7 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to high prevalence of malaria in tropical regions, widespread use of chloroquine and artemisinin, global health initiatives like who malaria programs, increased funding for malaria research, improvements in diagnostic technologies.

What Is The Malaria Treatment Market Growth Forecast?

The malaria treatment market size is expected to see strong growth in the next few years. It will grow to $2.18 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to development of new antimalarial vaccines, rise in drug-resistant malaria strains, adoption of digital health monitoring systems, expansion of healthcare infrastructure in africa and asia, growth in public-private partnerships for malaria eradication. Major trends in the forecast period include rapid diagnostic technology adoption, expansion of antimalarial drug pipeline, growth of vaccine development programs, increasing awareness and preventive measures, integration of telemedicine for malaria management.

Global Malaria Treatment Market Segmentation

1) By Treatment: Prescription Medications, Vaccines, Diagnostic Tests, Other Treatments 2) By Route Of Administration: Oral, Parenteral, Intravenous 3) By Distribution Channel: Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels 4) By End User: Hospitals, Specialty Clinics, Homecare, Other End Users Subsegments: 1) By Prescription Medications: Antimalarial Drugs, Prophylactic Medications 2) By Vaccines: RTS,S Or AS01, Other Experimental Vaccines 3) By Diagnostic Tests: Rapid Diagnostic Tests, Microscopy-Based Tests, Polymerase Chain Reaction (PCR) Tests 4) By Other Treatments: Supportive Care, Herbal Remedies, Vector Control Measures

What Are The Drivers Of The Malaria Treatment Market?

The high incidence of malaria is expected to propel the growth of the malaria treatment market going forward. Malaria refers to a potentially life-threatening mosquito-borne disease caused by the Plasmodium parasite, characterized by recurring fever and other flu-like symptoms. This shift has resulted from poverty, limited access to healthcare services, climate change, lack of malaria control measures, and drug resistance. Malaria treatment helps to effectively manage and cure the infection caused by the Plasmodium parasite. For instance, in December 2024, according to the UK Health Security Agency, a UK-based government department, imported malaria cases in the UK reached 2,106 in 2023, representing a 26% rise from 2022, with England reporting 1,977 cases and the remainder distributed across Scotland, Wales, and Northern Ireland. Therefore, the high incidence of malaria is driving the growth of the malaria treatment industry. The increase in healthcare spending is expected to propel the growth of the malaria treatment market going forward. Healthcare spending refers to the total amount of financial resources allocated to the healthcare sector within a specific region, country, or organization. Healthcare spending on malaria treatment is crucial for effectively managing and preventing the spread of the disease, and ensuring access to prompt diagnosis, antimalarial medications, and preventive measures. For instance, in April 2025, according to the Office for National Statistics (ONS), a UK-based independent producer of official statistics, total healthcare expenditure rose by 6.5% in nominal terms and 2.4% in real terms between 2023 and 2024, while healthcare’s share of GDP held steady at 11.1% in 2024. Therefore, an increase in healthcare spending is driving the growth of the malaria treatment industry.

Key Players In The Global Malaria Treatment Market

Major companies operating in the malaria treatment market are Pfizer Inc., Merck & Co., Johnson & Johnson, Roche Holding AG, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca Plc, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Viatris Inc., Sun Pharmaceutical Industries Ltd., Serum Institute of India, Cipla Ltd., Amneal Pharmaceuticals LLC, Lupin Ltd., Zydus Lifesciences Limited, Ipca Laboratories Ltd., Chongqing Holley Pharmaceutical Co. Ltd., Strides Pharma Science Limited, AdvaCare Pharma USA LLC, Actiza Pharmaceutical Private Limited

Regional Insights

Middle East and Africa was the largest region in the malaria treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Need data on a specific region in this market?

What Defines the Malaria Treatment Market?

The malaria treatment market consists of sales of antimicrobial medications, antimalarial drugs, antipyretics, intravenous fluids, and supportive care products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Malaria Treatment Market Report 2026?

The malaria treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the malaria treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Malaria Treatment Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$1.7 billion
Revenue Forecast In 2035$2.18 billion
Growth RateCAGR of 5.6% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredTreatment, Route Of Administration, Distribution Channel, End User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies ProfiledPfizer Inc., Merck & Co., Johnson & Johnson, Roche Holding AG, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca Plc, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Viatris Inc., Sun Pharmaceutical Industries Ltd., Serum Institute of India, Cipla Ltd., Amneal Pharmaceuticals LLC, Lupin Ltd., Zydus Lifesciences Limited, Ipca Laboratories Ltd., Chongqing Holley Pharmaceutical Co. Ltd., Strides Pharma Science Limited, AdvaCare Pharma USA LLC, Actiza Pharmaceutical Private Limited
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Frequently Asked Questions

The Malaria Treatment market was valued at $1.61 billion in 2025, increased to $1.7 billion in 2026, and is projected to reach $2.18 billion by 2030.
request a sample here
The global Malaria Treatment market is expected to grow at a CAGR of 6.5% from 2026 to 2035 to reach $2.18 billion by 2035.
request a sample here
Some Key Players in the Malaria Treatment market Include, Pfizer Inc., Merck & Co., Johnson & Johnson, Roche Holding AG, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca Plc, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Viatris Inc., Sun Pharmaceutical Industries Ltd., Serum Institute of India, Cipla Ltd., Amneal Pharmaceuticals LLC, Lupin Ltd., Zydus Lifesciences Limited, Ipca Laboratories Ltd., Chongqing Holley Pharmaceutical Co. Ltd., Strides Pharma Science Limited, AdvaCare Pharma USA LLC, Actiza Pharmaceutical Private Limited .
request a sample here
Major trend in this market includes: Vaccine Rollouts Lead the Fight Against Malaria: Gavi Launches R21 Vaccine to Protect Children Under Five. For further insights on this market.
request a sample here
Middle East and Africa was the largest region in the malaria treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the malaria treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here
Research Expert

Book your 30 minutes free consultation with our research experts

Chat with us